CLINICAL OUTCOMES OF ORAL ANTICOAGULATION AND NO ANTICOAGULATION AMONG END-STAGE RENAL DISEASE PATIENTS ON MAINTENANCE HEMODIALYSIS WITH ATRIAL FIBRILLATION: A SINGLE-CENTER PROSPECTIVE COHORT STUDY

被引：0
|
作者：
Polito, Eratosthenes [1 ]
Darunday, Grecia [1 ]
机构：
[1] Perpetual Succour Hosp, Sect Adult Nephrol, Dept Internal Med, Cebu, Philippines
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2020年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
P1301
引用
收藏
页码：1624 / 1624
页数：1
相关论文
共 50 条
  • [1] Oral Anticoagulation and Cardiovascular Outcomes in Patients With Atrial Fibrillation and End-Stage Renal Disease
    Pokorney, Sean D.
    Black-Maier, Eric
    Hellkamp, Anne S.
    Friedman, Daniel J.
    Vemulapalli, Sreekanth
    Granger, Christopher B.
    Thomas, Laine
    Peterson, Eric D.
    Piccini, Jonathan P., Sr.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 1299 - 1308
  • [2] CLINICAL OUTCOMES OF ORAL ANTICOAGULATION AND NO ANTICOAGULATION AMONG HEMODIALYSIS PATIENTS WITH ATRIAL FIBRILLATION
    Polito, Eratosthenes
    Darunday, Grecia
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 : I1209 - I1211
  • [3] Reply: Oral Anticoagulation and Cardiovascular Outcomes in Patients With Atrial Fibrillation and End-Stage Renal Disease
    Pokorney, Sean D.
    Black-Maier, Eric
    Piccini, Jonathan P.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 76 (03) : 351 - 352
  • [4] Atrial fibrillation in patients with end-stage renal disease on hemodialysis: Magnitude of the problem and new approach to oral anticoagulation
    Koenigsbruegge, Oliver
    Ay, Cihan
    [J]. RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2019, 3 (04) : 578 - 588
  • [5] Oral Anticoagulation in Patients With End-Stage Kidney Disease on Dialysis and Atrial Fibrillation
    Hu, Austin
    Niu, Jingbo
    Winkelmayer, Wolfgang C.
    [J]. SEMINARS IN NEPHROLOGY, 2018, 38 (06) : 618 - 628
  • [6] Use of Oral Anticoagulation for Patients With Atrial Fibrillation and End-stage Renal Disease: What Is Needed Nowadays?
    Li, Jun
    Liu, Xinyue
    Zheng, Sulin
    Huang, Yuli
    [J]. REVISTA ESPANOLA DE CARDIOLOGIA, 2019, 72 (01): : 96 - 97
  • [7] Percutaneous left atrial appendage closure, a safe alternative to anticoagulation for patients with nonvalvular atrial fibrillation and end-stage renal disease on hemodialysis: A single center experience
    Xipell, Marc
    Flores-Umanzor, Eduardo
    Ojeda, Raquel
    Arias, Marta
    Cepas-Guillen, Pedro L.
    Regueiro, Ander
    Freixa, Xavier
    Cases, Aleix
    Maduell, Francisco
    [J]. ARTIFICIAL ORGANS, 2020, 44 (05) : 513 - 521
  • [8] Anticoagulation in Patients with End-Stage Renal Disease and Atrial Fibrillation: Confusion, Concerns and Consequences
    Goel, Narender
    Jain, Deepika
    Haddad, Danny B.
    Shanbhogue, Divya
    [J]. JOURNAL OF STROKE, 2020, 22 (03) : 306 - 316
  • [9] Anticoagulation for Patients With Atrial Fibrillation and End-Stage Renal Disease on Dialysis: A National Survey
    Halperin, Laura F.
    Lee, May K.
    Liew, Janet
    Lauck, Sandra
    Kong, Darren
    Krahn, Andrew D.
    Deyell, Marc W.
    Andrade, Jason G.
    Hawkins, Nathaniel M.
    Chakrabarti, Santabhanu
    Yeung-Lai-Wah, Ah Fan John
    Bennett, Matthew T.
    Cheung, Christopher
    Levin, Adeera
    Schwartz, Daniel I.
    Laksman, Zachary W.
    [J]. CANADIAN JOURNAL OF CARDIOLOGY, 2021, 37 (06) : 924 - 928
  • [10] Oral anticoagulation in end-stage renal disease and atrial fibrillation: is it time to just say no to drugs?
    Black-Maier, Eric
    Piccini, Jonathan P.
    [J]. HEART, 2017, 103 (11) : 807 - 808
12345